The research team, led by Tzi Shin Toh, Chun Wie Chong, and Ai Huey Tan, with colleagues spanning neurology, medical microbiology, physiology, and computer science at Universiti Malaya, Monash University Malaysia, and Korea University, enrolled 67 people with Parkinson’s disease and 64 non-Parkinson’s controls. Rather than examining a single molecular layer in isolation, they integrated three complementary datasets: untargeted serum metabolomics and untargeted fecal metabolomics, both performed using liquid chromatography-mass spectrometry, alongside 16S rRNA gene sequencing of the gut microbiome. This combination allowed them to simultaneously survey what microbes are present in the gut, what metabolic products accumulate in feces, and what small molecules travel through the blood.

The most striking finding concerned lipids. Parkinson’s disease patients exhibited widespread lipid dysregulation, with measurable alterations in serum isoprenoids, a class of molecules built from repeating five-carbon units that feed into cholesterol synthesis and protein modification pathways. Intriguingly, the researchers also detected changes in a bacteria-derived precursor of isoprenoids, 2-C-methyl-D-erythritol 4-phosphate, a compound produced through the MEP pathway used by many bacteria rather than the classical mevalonate pathway of human cells. Its presence and perturbation in the serum of Parkinson’s patients hints that some of the lipid abnormalities in the disease may originate not from human biochemistry but from the metabolic machinery of gut microbes themselves.

Beyond isoprenoids, the team documented disturbances in two other lipid families with well-established roles in cellular life: sphingolipids and glycerophospholipids. Sphingolipids are structural components of cell membranes and key signaling molecules, and their disruption has been implicated in neurodegeneration, including the alpha-synuclein aggregation that defines Parkinson’s pathology. Glycerophospholipids, meanwhile, form the backbone of every cellular membrane and participate in inflammatory signaling. The study also found perturbations in fatty acid biosynthesis pathways, suggesting that the lipid economy of Parkinson’s patients is broadly, rather than narrowly, remodeled. Together, these findings position lipid metabolism as a central arena in which host and microbial biology interact in the disease.

To make sense of the three data layers at once, the researchers applied multi-omics integration methods, asking which of the molecular and microbial datasets carried the strongest statistical association with Parkinson’s disease status. The answer was clear: the disease was more closely associated with the gut microbiome and serum metabolomics than with the fecal metabolome. In other words, the combination of who lives in the gut and what circulates in the blood proved more informative about disease state than the raw metabolic contents of stool. This kind of integrative conclusion is difficult to reach from any single omics platform and underscores the value of measuring multiple molecular domains in the same individuals.

One specific microbial-metabolite pairing stood out. Serum levels of N-hydroxy-L-phenylalanine, a modified amino acid, were linked to Desulfovibrio, a genus of sulfate-reducing bacteria known to produce hydrogen sulfide. Desulfovibrio has attracted attention in Parkinson’s research before, partly because hydrogen sulfide can influence mitochondrial function and gut barrier integrity, and partly because the genus has been repeatedly reported as enriched in the gut microbiomes of patients. The new association implicates microbial amino acid metabolism as a plausible contributor to the systemic metabolic shifts seen in the disease, adding a concrete biochemical thread to what has often been a correlational literature.

Perhaps the most clinically provocative result came from machine learning. The team trained predictive models to estimate clinical features of Parkinson’s disease from the multi-omics data and found that cognition was predicted more robustly than motor impairment. Cognitive decline is one of the most feared and difficult-to-manage aspects of Parkinson’s disease, and objective biomarkers that track it remain scarce. The fact that a model built from molecular and microbial features could predict cognitive performance more reliably than motor scores suggests that the gut-metabolic axis may be more tightly coupled to the non-motor dimensions of the disease than to its classical movement symptoms.

Equally notable was the composition of the predictive features. The models predicting cognition were driven exclusively by gut-derived features, including short-chain fatty acid-producing taxa, opportunistic pathogens, and fecal lipid metabolites. No serum metabolites contributed to the cognitive predictions. Short-chain fatty acids and their producing bacteria are central players in gut-brain signaling, influencing immune tone, barrier function, and even microglial activity in the brain. Opportunistic pathogens, by contrast, are organisms that typically lurk harmlessly but can flourish under dysbiotic conditions, and their presence alongside beneficial taxa in the predictive set paints a picture in which both the loss of protective functions and the gain of potentially harmful ones shape the cognitive landscape of Parkinson’s disease.

The authors emphasize that these findings highlight novel microbial-driven lipid and amino acid pathways with potential biomarker and therapeutic relevance in Parkinson’s disease. The implications run in two directions. As biomarkers, gut microbial taxa and fecal lipid metabolites could eventually complement clinical assessment, particularly for tracking cognitive trajectory, where current tools are limited. As therapeutic targets, the MEP pathway and the metabolic activities of organisms like Desulfovibrio offer possibilities that conventional neurology has never considered: modulating specific bacterial metabolic outputs rather than neurons directly. Neither application is imminent, and the study’s cross-sectional design means that causality remains unresolved, but the specificity of the molecular signals gives both avenues a concrete starting point.

The study also carries methodological weight. By combining untargeted metabolomics in two compartments with microbiome sequencing and machine learning in a single cohort, the researchers demonstrated a template for how gut-brain research can move beyond simple association studies toward mechanistically annotated, clinically oriented signatures. The work was funded by the Ministry of Higher Education Malaysia through a Fundamental Research Grant Scheme awarded to Ai Huey Tan, and it reflects a growing recognition that Parkinson’s disease research is a genuinely multi-system endeavor. For patients and clinicians, the message is that the gut is not merely a bystander in Parkinson’s disease; it is an active metabolic participant whose chemical output, measurable in blood and stool, appears to track with some of the most burdensome features of the illness. As larger and longitudinal studies build on these findings, the microbial and metabolic markers identified here may help define which biological pathways deserve the next generation of therapeutic attention.

Subject of Research: Host–gut microbiome metabolic crosstalk in Parkinson's disease

Article Title: Multi-omics of host–gut metabolic crosstalk in Parkinson’s disease

Article References: Multi-omics of host–gut metabolic crosstalk in Parkinson’s disease. (n.d.). https://doi.org/10.1038/s41531-026-01561-y

Image Credits: AI Generated

DOI: 10.1038/s41531-026-01561-y

Keywords: Parkinson's disease, gut microbiome, metabolomics, multi-omics, lipid metabolism, Desulfovibrio, sphingolipids, short-chain fatty acids, machine learning, cognition, 16S rRNA sequencing, gut-brain axis

The research team, led by scientists at Nankai University in Tianjin with collaborators at Tianjin University of Science and Technology, analyzed original samples from the Chengbei Oilfield to reconstruct the structure and function of its reservoir microbiome. Sulfate-reducing bacteria, often abbreviated SRB, occupy a unique metabolic niche: they respire sulfate rather than oxygen, and in doing so they release sulfide as a waste product. Because oil reservoirs are typically anoxic and rich in both sulfate and hydrocarbons, they are natural incubators for these organisms. Yet not all SRB contribute equally to souring, and the new work demonstrates that community composition alone is a misleading guide to ecological impact.

One of the clearest signals to emerge from the integrated metagenomic and culture-based analyses was the dominant influence of temperature. Across the sampling wells, temperature emerged as the key factor shaping the structure of the SRB community, and the highest hydrogen sulfide production rates were recorded under high-temperature conditions at 60 degrees Celsius. This finding matters practically as well as conceptually. It suggests that the hotter zones of a reservoir — precisely the regions where thermodynamic energy yields and reaction rates are elevated — harbor the microbial communities most capable of generating sulfide at industrial scales. Any monitoring or mitigation program that samples only from cooler, more accessible wells may be looking in the wrong place entirely.

The pivotal conceptual advance of the study lies in distinguishing activity from abundance. Within the SRB community, two genera, Desulfofundulus and Desulfotomaculum, represented only 3.13 percent and 6.41 percent of the community respectively. Despite their numerical obscurity, their presence correlated strongly with hydrogen sulfide accumulation, a relationship that held statistical significance. In stark contrast, Desulfovibrio, which made up a commanding 46.20 percent of the community, showed no significant correlation with sulfide levels at all. In other words, the organism that dominated by headcount was largely a bystander, while the rare players were doing the heavy metabolic lifting. The authors propose that it is highly active — rather than highly abundant — SRB that drive biogenic hydrogen sulfide production, a reframing with profound implications for how reservoir microbiomes are assessed.

Why would rarity and activity go hand in hand? The answer appears to lie in metabolic capability. Abundance in a microbial community reflects success at persisting under prevailing conditions, but it does not necessarily reflect throughput of the specific reaction that matters — in this case, the reduction of sulfate to sulfide coupled to the oxidation of hydrocarbons. The rare, high-activity taxa possess enzymatic machinery and substrate preferences that allow them to metabolize crude oil components directly, channeling the electrons from those hydrocarbons into sulfate respiration at remarkable rates. The abundant taxa may be surviving on more dilute substrates or filling entirely different roles in the sulfur and carbon cycles, contributing little to the sulfide budget even while dominating sequence libraries.

Metabolic modeling added a second crucial layer to the story: cooperation. Using genome-scale metabolic models, the researchers revealed syntrophic interactions between the SRB — including Desulfofundulus and Desulfotomaculum — and hydrocarbon-degrading microorganisms. In syntrophy, one organism’s metabolic waste becomes another’s food, and the partners can together accomplish transformations that neither could achieve alone. Hydrocarbon-oxidizing bacteria break down complex oil molecules into smaller organic compounds such as lactate, acetate, and alcohols, which the sulfate reducers can then consume while respiring sulfate. The modeling results highlight this microbial cooperation as an accelerator of souring, suggesting that the rate-limiting step in sulfide production may often be the availability of suitable fermentation products rather than the sulfate reducers themselves. Souring, in this view, is not a single-species problem but a community-level supply chain.

To test these inferences directly, the team isolated two living strains from the reservoir material: Desulfofundulus sp. 13T and Desulfotomaculum sp. 45–6. In pure culture, the two organisms revealed strikingly different metabolic strategies for sulfide production, governed by their inherent metabolic capacities and substrate preferences. Desulfofundulus sp. 13T emerged as the key species. It could degrade n-hexadecane, a representative long-chain alkane, by 67.79 percent within ten days, and it could also consume crude oil directly. Fed on lactate, it produced more than 2000 ppm of hydrogen sulfide within 24 hours, and even on hydrocarbon substrates it generated over 1000 ppm of the gas in just three days. These are extraordinary rates for an organism cultured from a deep reservoir, and they confirm that strain 13T can couple alkane oxidation to sulfate reduction without needing an intermediary partner.

Desulfotomaculum sp. 45–6 told a different story. This strain demonstrated only limited capacity to degrade alkanes, and it could produce less than 1000 ppm of hydrogen sulfide, and only when the culture medium was supplemented with methanol or lactate. Without such pre-processed carbon sources, its sulfide output collapsed. This substrate dependence is precisely the kind of trait that syntrophic modeling predicted: strain 45–6 likely relies on hydrocarbon degraders to supply it with fermentable intermediates in the reservoir. The two isolates thus occupy distinct functional niches, and the authors emphasize that their respective roles and contributions to ecosystem functions, particularly hydrogen sulfide production, are not equivalent. A community survey that simply reported ‘SRB present’ would flatten this critical functional diversity into a single misleading number.

The study’s overarching conclusion — that metabolic activity, not relative abundance, is the key predictor of the environmental impact of sulfate-reducing bacteria — offers the industry a trait-based framework for souring management. Today, souring is typically controlled by continuous injection of biocides or nitrate into the reservoir. Nitrate addition works by stimulating nitrate-reducing bacteria that outcompete SRB for electron donors and can even oxidize sulfide back to benign forms. But such treatments are expensive, blunt, and applied reservoir-wide. If the true culprits are a small number of high-activity taxa like Desulfofundulus sp. 13T, then interventions could be targeted with far greater precision: monitoring programs could track the activity of specific functional genes, such as those encoding dissimilatory sulfite reductase, rather than merely counting 16S sequences; biocide strategies could be tuned to the temperature and substrate conditions favored by the dangerous taxa; and nitrate dosing could be concentrated where syntrophic hydrocarbon-degrading consortia are most active.

There are broader lessons here for microbiology at large. The finding that rare taxa can dominate ecosystem function echoes discoveries from soils, oceans, and the human gut, where low-abundance organisms frequently punch far above their weight. The Chengbei study is among the most complete demonstrations of this principle in the deep subsurface, because it closes the loop from field observation through community modeling to cultured organisms and measured fluxes. It also underscores the value of coupling cultivation with metagenomics: sequencing revealed who was there, but only the lab work could reveal what they could do, how fast, and on which substrates. As energy companies probe deeper and hotter reservoirs, and as microbial enhanced oil recovery techniques deliberately inject microbes into the subsurface, understanding which organisms actually drive sulfide production will become only more urgent. For now, the message from Bohai Bay is clear: in the underground economy of oil reservoirs, it is not the size of the workforce that matters, but the metabolic intensity of a few exceptional workers — and the networks of partners that keep them fed.

Subject of Research: The role of highly active sulfate-reducing bacteria and their syntrophic interactions in biogenic hydrogen sulfide production and reservoir souring.

Article Title: Highly active sulfate-reducing bacteria drive biogenic souring in oil reservoirs: insights from metabolic capability and microbial interactions

Article References: Highly active sulfate-reducing bacteria drive biogenic souring in oil reservoirs: insights from metabolic capability and microbial interactions. (n.d.). https://doi.org/10.1186/s40168-026-02523-5

Image Credits: AI Generated

DOI: 10.1186/s40168-026-02523-5

Keywords: sulfate-reducing bacteria, hydrogen sulfide, biogenic souring, oil reservoirs, reservoir microbiome, Desulfofundulus, Desulfotomaculum, Desulfovibrio, metagenomics, syntrophy, temperature, hydrocarbon degradation